135 related articles for article (PubMed ID: 32536202)
1. MicroRNA-892a regulates laryngocarcinoma cell proliferation via Dicer.
Dong J; Wang J; Shan C; Zhang H; Xu O
Exp Biol Med (Maywood); 2020 Aug; 245(14):1222-1232. PubMed ID: 32536202
[TBL] [Abstract][Full Text] [Related]
2. miR-892a regulated PPP2R2A expression and promoted cell proliferation of human colorectal cancer cells.
Liang WL; Cao J; Xu B; Yang P; Shen F; Sun Z; Li WL; Wang Q; Liu F
Biomed Pharmacother; 2015 May; 72():119-24. PubMed ID: 26054685
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-384 regulates cell proliferation and apoptosis through directly targeting WISP1 in laryngeal cancer.
Wang L; Sun J; Cao H
J Cell Biochem; 2019 Mar; 120(3):3018-3026. PubMed ID: 30548664
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
Ye J; Li L; Feng P; Wan J; Li J
Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of miR-892a in gastric cancer and its regulatory effect on tumor progression.
Lv J; Zhang H; Gao Z; Zhang X; Huang X; Jia X
Cancer Biomark; 2020; 28(2):247-254. PubMed ID: 32390603
[TBL] [Abstract][Full Text] [Related]
6. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
7. Long non-coding RNA CCAT1/miR-218/ZFX axis modulates the progression of laryngeal squamous cell cancer.
Zhang Y; Hu H
Tumour Biol; 2017 Jun; 39(6):1010428317699417. PubMed ID: 28631575
[TBL] [Abstract][Full Text] [Related]
8. LncRNA SNHG3 regulates laryngeal carcinoma proliferation and migration by modulating the miR-384/WEE1 axis.
Wang L; Su K; Wu H; Li J; Song D
Life Sci; 2019 Sep; 232():116597. PubMed ID: 31238052
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of long noncoding RNA TUG1 contributes to the development of laryngocarcinoma by targeting miR-145-5p/ROCK1 axis.
Zhuang S; Liu F; Wu P
J Cell Biochem; 2019 Aug; 120(8):13392-13402. PubMed ID: 30916820
[TBL] [Abstract][Full Text] [Related]
10. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
11. MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.
Chang W; Liu M; Xu J; Fu H; Zhou B; Yuan T; Chen P
Tumour Biol; 2016 Nov; 37(11):14813-14824. PubMed ID: 27638830
[TBL] [Abstract][Full Text] [Related]
12. miR-632 Promotes Laryngeal Carcinoma Cell Proliferation, Migration, and Invasion Through Negative Regulation of GSK3β.
Zhou ZX; Zhang ZP; Tao ZZ; Tan TZ
Oncol Res; 2020 Feb; 28(1):21-31. PubMed ID: 29562960
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal regulation of miR-1205 and E2F1 modulates progression of laryngeal squamous cell carcinoma.
Li P; Lin XJ; Yang Y; Yang AK; Di JM; Jiang QW; Huang JR; Yuan ML; Xing ZH; Wei MN; Li Y; Yuan XH; Shi Z; Liu H; Ye J
Cell Death Dis; 2019 Dec; 10(12):916. PubMed ID: 31801947
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA 32 promotes cell proliferation, migration, and suppresses apoptosis in colon cancer cells by targeting OTU domain containing 3.
Jin Y; Cheng H; Cao J; Shen W
J Cell Biochem; 2019 Nov; 120(11):18629-18639. PubMed ID: 31338872
[TBL] [Abstract][Full Text] [Related]
15. miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma.
Mao Y; Liu J; Zhang D; Li B
Tumour Biol; 2016 Jul; 37(7):9009-22. PubMed ID: 26758433
[TBL] [Abstract][Full Text] [Related]
16. LncRNA MEG3 inhibits cell proliferation and induces apoptosis in laryngeal cancer via miR-23a/APAF-1 axis.
Zhang X; Wu N; Wang J; Li Z
J Cell Mol Med; 2019 Oct; 23(10):6708-6719. PubMed ID: 31328388
[TBL] [Abstract][Full Text] [Related]
17. Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met.
Cai KM; Bao XL; Kong XH; Jinag W; Mao MR; Chu JS; Huang YJ; Zhao XJ
Int J Mol Med; 2010 Apr; 25(4):565-71. PubMed ID: 20198305
[TBL] [Abstract][Full Text] [Related]
18. Expressions of miR-122a and miR-3195 in laryngeal cancer and their effects on the proliferation and apoptosis of laryngeal cancer cell Hep-2.
Jiang X; Gao Z; Tian L; Liu M
Adv Clin Exp Med; 2020 May; 29(5):525-534. PubMed ID: 32469167
[TBL] [Abstract][Full Text] [Related]
19. CYP1A1 is a target of miR-892a-mediated post-transcriptional repression.
Choi YM; An S; Lee EM; Kim K; Choi SJ; Kim JS; Jang HH; An IS; Bae S
Int J Oncol; 2012 Jul; 41(1):331-6. PubMed ID: 22470100
[TBL] [Abstract][Full Text] [Related]
20. MiR-128 suppresses the growth of thyroid carcinoma by negatively regulating SPHK1.
Cao XZ; Bin H; Zang ZN
Biomed Pharmacother; 2019 Jan; 109():1960-1966. PubMed ID: 30551451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
